Sigma Healthcare (ASX:SIG)
reports that the transformation of their business has left them unable to pay a fully franked dividend in 2020.
The company does remain on target to deliver FY20 Underlying EBITDA guidance of approximately $46-47 million.
Sigma CEO and Managing Director Mark Hooper says “Our underlying business is performing strongly, with FY20 financial results remaining on track.”
Shares in Sigma Healthcare (ASX:SIG)
are trading 0.85 per cent lower at 58 cents.